Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: gene novak who wrote (971)	8/14/1998 9:09:00 AM
From: Jack Ucci	Respond to of 1605

I doubt it. It has provided some momentary strength. In any case news of this sort has not materially affected the stock price in the recent past. The stockalert news announcement had much more effect, but only momentarily. Vaso's business strategy seems aimed at achieving technical medical acceptance as a path to increasing revenues. With so many shares outstanding they seem quite a ways from profitability. But their strategy seems to be working (rather slowly). On the other side of the coin their expenditures are also increasing. They seem to be in no rush to attend to shareholder value. The danger here is that rival cardiac therapies will develop before they score major marketing success. My hopes of seeing $4 on this stock are shrinking daily, and I have been a shareholder since shortly before their spike above $4. Can anyone else speak to a different point of view? Jack

To: gene novak who wrote (971)	8/14/1998 9:58:00 AM
From: Jack Ucci	Respond to of 1605

Nice first three minutes of trading this morning, so at least there is some buying interest in vaso...at these prices. The price has settled down to 1.15 x 1.18. Jack